![]() In the frame to your right, you can see an eye with diabetic macular edema, and this eye has most of the features of non-proliferative diabetic retinopathy, including hemorrhages, microaneurysms, exudates, and cotton wool patches, suggesting ischemia and edema. They're extraordinarily effective, but there are some barriers to outcomes that we're going to go over right now. Treatment with intravitreal anti-VEGF or VEGF inhibitors is the standard of care for both of these conditions, that is exudative AMD and diabetic macular edema. Neovascular AMD is the leading cause of precipitous visual loss in people over 60 in the United States, and diabetic macular edema contributes significantly to diabetic blindness, which is the leading cause of blindness in working-age Americans. As you all know, these are enormous public health issues. Schwartz, MD: Tonight, we're going to spend a little bit of time talking about an overview of age-related macular degeneration, diabetic macular edema, and then dive into some issues about improving outcomes through scientific innovation and focus specifically on faricimab or Vabysmo. He is licensed as a CPA in New York Florida and the U.S. He has presented to the California Primary Care Association (CPCA), the Bi-State Primary Care Association (serving Vermont and New Hampshire), the Community Health Center Association of Connecticut (CHCACT), the Georgia Primary Care Association (GPCA), and the Community Health Care Association of New York State (CHCANYS), as well as at the National Association of Community Health Centers (NACHC) conferences and trainings. In addition to his work on internal training for the firm, Steve also lectures on financial and regulatory topics of note within the healthcare industry through various external webinars and speaking engagements at board trainings. More recently, Steve has provided clients with guidance relating to the Provider Relief Fund (PRF) and other government relief programs available through the CARES and American Rescue Plan Acts, and the Paycheck Protection Program (PPP), through his role as a member of the firm’s SBA Task Force. He is exceptionally knowledgeable in critical areas that impact his clients, such as the 340B Drug Pricing Program, Medicare/Medicaid cost reports, Federal Financial Reports (FFR), and Uniform Data System (UDS) reports, as well as other government regulatory reports required by the Department of Health & Human Services (HHS). Steve performs auditing, accounting, and management advisory services for clients and has extensive knowledge in Generally Accepted Government Auditing Standards (GAGAS) and Federal Single Audit under the Uniform Guidance (formerly OMB Circular A-133). His clients include community/migrant health centers, foster care agencies, health homes, homeless programs, HIV programs, drug treatment programs, prepaid health service plans, adult day care centers, and other not-for-profit organizations and for-profit corporations. With 25 years of experience in the healthcare field, Steve concentrates his practice on serving FQHCs. ![]() Schwartz, CPA, a partner with CohnReznick, leads the Healthcare Industry Practice in our New York office, and is a member of the Firm’s Not-for-Profit and Education Industry Practice. ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |